Top compounds associated with response to ABL1


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.03 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA tivozanib CTRPv2 pan-cancer AAC 0.11 0.004
mRNA tosedostat CTRPv2 pan-cancer AAC 0.016 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.068 0.03
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.044 0.3
mRNA triptolide CTRPv2 pan-cancer AAC 0.058 0.1
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.044 0.4
Download CSV